方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 纤维肌痛影响问卷× | EORTC QLQ-C30：癌症生活质量评估的核心问卷× | |
|---|---|---|
| 领域 | 健康结局 | 健康结局 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1991 | 1993 |
| 提出者≠ | Cynthia S. Burckhardt et al. | Nico Aaronson et al. |
| 类型≠ | Self-report symptom and functional impairment questionnaire | Self-report quality of life questionnaire |
| 开创性文献≠ | Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735. link ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 别名 | FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 相关≠ | 4 | 5 |
| 摘要≠ | The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGate数据集 ↗ |
|
|